Key result
Prophylactic administration of the M8 antibody at 2.5 mg/kg protected 75% of guinea pigs from foot-and-mouth disease virus infection.
Why the study?
Antigenic diversity and short duration of vaccine-induced protection limit current foot-and-mouth disease vaccines, necessitating a deeper understanding of the molecular basis of neutralization to aid broad-spectrum vaccine design.
Structural analysis of FMDV neutralizing antibodies M8 and M170 reveals distinct binding mechanisms, providing targets for broad-spectrum vaccine design and antigen detection.
Foot-and-mouth disease (FMD) is an economically devastating and highly contagious viral disease of cloven-hoofed animals with a global distribution. The causative agent, FMD virus (FMDV) is a small non-enveloped RNA virus, belonging to the Aphthoviruses genus within Picornaviridae family (Tuthill et al., 2010). Control of FMD has been largely reliant on vaccinations with inactivated virus vaccines. However, significant antigenic diversity within FMDV serotypes and inability of the vaccines to induce immune protection for a long duration of time impinge on the efficacy of available vaccines. The roles of neutralizing antibodies (NAbs) as the principal protective components of the immune responses to FMDV vaccination or infection have been well established (Pay and Hingley, 1987; Juleff et al., 2009). Passive immunization of NAbs has also been demonstrated to be effective in curing FMD and many viral diseases (Harmsen et al., 2007; Qiu et al., 2018). A deep understanding of the molecular basis for viral neutralization by antibodies and the identification of key viral epitopes would aid in the development of potent rationally designed broad-spectrum vaccine.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2021) conducted a letter in Foot-and-mouth disease (FMD). M8 and M170 neutralizing antibodies vs. PBS control was evaluated on Protection from FMD symptoms in prophylactic mode. Prophylactic administration of the M8 antibody at 2.5 mg/kg protected 75% of guinea pigs from foot-and-mouth disease virus infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: